Topline results from the SURPASS-CVOT trial show that once-weekly tirzepatide has a cardiovascular risk profile similar to ...

GLP-1 medications like semaglutide and tirzepatide are helping people shed weight and keep it off. But let’s be clear: These aren’t miracle pills you buy off ...

Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...

The fast-selling GLP-1 drug matched Lilly's older medicine Trulicity in a closely watched cardiovascular outcomes trial, ...

SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.

An appeals court let Donald Trump retain control over California's National Guard while the state's governor proceeds with a lawsuit challenging the president.

Weight gain, low energy and stalled progress at the gym are issues many men face as they get older. But a new wave of ...

Whether as a topic for daily conversation or via ads on seemingly every platform, GLP-1 medications are pretty impossible to avoid nowadays. But here's a quick recap, in case you've been fully off the ...

Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...

FAT jabs do often sound like a magical quick fix to overeating and demanding hunger pangs.  But the drugs can leave some ...

These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...